Chronic intestinal inflammation can affect heart through changes in gut microbiota and immune cells, study finds
Chronic intestinal inflammation drives cardiac dysfunction through a gut microbiota-dependent pathway, suggesting a potential therapeutic target for reducing cardiovascular risk in patients with inflammatory bowel disease (IBD), according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Deep learning model using ECGs during sleep studies can predict cardiovascular outcomes
United Kingdom
-
Certain diets are linked to better cognitive performance, new study finds
United Kingdom
-
Improving healthcare sustainability through carbon data
United Kingdom
-
Immune cell map uncovers how individual aging trajectories diverge
United Kingdom
-
Late-night eating linked to higher rates of fatty liver disease and cirrhosis
United Kingdom
-
Students from military families are often misunderstood in US public schools—experts explain what schools can do
United Kingdom
-
After-school-based intervention helps steer children toward healthier BMI scores
United Kingdom
-
Alternative signaling pathway improves transplantation of blood stem cells
United Kingdom